Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms

Bioscience, Biotechnology and Biochemistry

Volumn 76, Issue 8, 2012, Pages 1518-1522

  Kumar, Hemant ^a   Kim, Byung Wook ^a   Song, Soo Yeol ^a   Kim, Jun Soo ^a   Kim, In Su ^a   Kwon, Young Sook ^b   Koppula, Sushruta ^a   Choi, Dong Kug ^a  

^a Konkuk University   (South Korea)

^b Joongbu University   (South Korea)

Author keywords

asarone; Acetylcholinesterase; Cognition; Passive avoidance; Y maze

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT DEFENSE; BENEFICIAL EFFECTS; CEREBRAL CORTEX; COGNITION; COGNITIVE DEFICITS; COGNITIVE FUNCTIONS; COGNITIVE IMPAIRMENT; COGNITIVE PERFORMANCE; ENHANCING EFFECT; MALONDIALDEHYDE; PASSIVE AVOIDANCE; SUPEROXIDE DISMUTASES; TRANSFER LATENCY; Y-MAZE;

ALDEHYDES; BRAIN; OXYGEN;

MAMMALS;

ACETYLCHOLINESTERASE; ANISOLE DERIVATIVE; ANTIOXIDANT; ASARONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MALONALDEHYDE; NOOTROPIC AGENT; SCOPOLAMINE BROMIDE; SUPEROXIDE DISMUTASE;

AMNESIA; ANIMAL; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; CHEMICALLY INDUCED DISORDER; COGNITION; DRUG ANTAGONISM; DRUG EFFECT; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY; METABOLISM; MOUSE; PSYCHOLOGICAL ASPECT;

ACETYLCHOLINESTERASE; AMNESIA; ANIMALS; ANISOLES; ANTIOXIDANTS; AVOIDANCE LEARNING; CEREBRAL CORTEX; CHOLINERGIC ANTAGONISTS; COGNITION; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; MICE; NOOTROPIC AGENTS; SCOPOLAMINE HYDROBROMIDE; SUPEROXIDE DISMUTASE;

MUS;

EID: 84865461054     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.120247     Document Type: Article

References (38)

1. El-Sherbiny DA, Khalifa AE, Attia AS, and Eldenshary Eel D, Pharmacol. Biochem. Behav., 76, 525-533 (2003).
2. Mountjoy CQ, Rossor MN, Iversen LL, and Roth M, Brain, 107 (Pt 2), 507-518 (1984).
3. Ovsepian SV, Anwyl R, and Rowan MJ, Eur. J. Neurosci., 20, 1267-1275 (2004).
4. Sarter M, Bodewitz G, and Stephens DN, Psychopharmacology (Berl), 94, 491-495 (1988).
5. Sunderland T, Tariot PN, Weingartner H, Murphy DL, New-house PA, Mueller EA, and Cohen RM, Prog. Neuropsycho-pharmacol. Biol. Psychiatry, 10, 599-610 (1986).
6. Bejar C, Wang RH, and Weinstock M, Eur. J. Pharmacol., 383, 231-240 (1999).
7. Braida D, Paladini E, Griffini P, Lamperti M, Maggi A, and Sala M, Eur. J. Pharmacol., 302, 13-20 (1996).
8. Giridharan VV, Thandavarayan RA, and Konishi T, Food Funct., 2, 320-327 (2011).
9. Koppula S and Choi DK, Pharm. Biol., 49, 702-708 (2011).
10. Martin SJ, Grimwood PD, and Morris RG, Annu. Rev. Neuro-sci., 23, 649-711 (2000).
11. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, and Davis KL, J. Neurochem., 64, 749-760 (1995).
12. Heinrich M and Lee Teoh H, J. Ethnopharmacol., 92, 147-162 (2004).
13. Cruz R, Almaguer Melian W, and Bergado Rosado JA, Rev. Neurol., 36, 877-886 (2003).
14. Floyd R, Proc. Soc. Exp. Biol. Med., 222, 236-245 (1999).
15. Schulz JB, Lindenau J, Seyfried J, and Dichgans J, Eur. J. Biochem., 267, 4904-4911 (2000).
16. Markesbery WR, Free Radic. Biol. Med., 23, 134-147 (1997).
17. Csernansky JG, Wang L, Miller JP, Galvin JE, and Morris JC, Arch. Neurol., 62, 1718-1722 (2005).
18. Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, Hyman BT, and Bacskai BJ, J. Neuropathol. Exp. Neurol., 65, 1082-1089 (2006).
19. Manyam BV, J. Altern. Complement. Med., 5, 81-88 (1999).
20. Limon ID, Mendieta L, Diaz A, Chamorro G, Espinosa B, Zenteno E, and Guevara J, Neurosci. Lett., 453, 98-103 (2009).
21. Pages N, Maurois P, Delplanque B, Bac P, Stables JP, Tamariz J, Chamorro G, and Vamecq J, Neurosci. Res., 68, 337-344 (2010).
22. Resendiz JS and Lerdo de Tejada A, J. Ethnopharmacol., 6, 239-242 (1982).
23. Manikandan S and Devi RS, Pharmacol. Res., 52, 467-474 (2005).
24. Cho J, Kim YH, Kong JY, Yang CH, and Park CG, Life Sci., 71, 591-599 (2002).
25. Kim DH, Jeon SJ, Son KH, Jung JW, Lee S, Yoon BH, Lee JJ, Cho YW, Cheong JH, Ko KH, and Ryu JH, Neurobiol. Learn. Mem., 87, 536-546 (2007).
26. Glowinski J, Axelrod J, and Iversen LL, J. Pharmacol. Exp. Ther., 153, 30-41 (1966).
27. Ellman GL, Courtney KD, Andres VJr, and Feather-Stone RM, Biochem. Pharmacol., 7, 88-95 (1961).
28. Fibiger HC, "The Biology of Memory, Symposia Medica, " ed. ILRSE Lindenlaub., Springer-Verlag, New York, pp. 35-47 (1990).
29. Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, van der Ploeg LH, and Sirinathsinghji DJ, Neuroscience, 90, 1-13 (1999).
30. Enz A, Amstutz R, Boddeke H, Gmelin G, and Malanowski J, Prog. Brain Res., 98, 431-438 (1993).
31. Hong SW, Yang JH, Joh EH, Kim HJ, and Kim DH, J. Ethnopharmacol., 134, 1010-1013 (2011).
32. Blokland A, Brain Res. Rev., 21, 285-300 (1995).
33. Apelt J, Bigl M, Wunderlich P, and Schliebs R, Int. J. Dev. Neurosci., 22, 475-484 (2004).
34. Lee MR, Yun BS, Park SY, Ly SY, Kim SN, Han BH, and Sung CK, J. Ethnopharmacol., 132, 70-74 (2010).
35. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, and Oliveira CR, Free Radic. Biol. Med., 44, 2051-2057 (2008).
36. Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, Ding J, and Geng M, Neurosci. Lett., 374, 222-226 (2005).
37. Jeong EJ, Ma CJ, Lee KY, Kim SH, Sung SH, and Kim YC, J. Ethnopharmacol., 121, 98-105 (2009).
38. Orhan I and Aslan M, J. Ethnopharmacol., 122, 327-332 (2009).